EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tremendous opportunities for health research have been unlocked by the recent expansion of big data and artificial intelligence. However, this is an emergent area where recommendations for optimal use and implementation are needed. The objective of these European League Against Rheumatism (EULAR) points to consider is to guide the collection, analysis and use of big data in rheumatic and musculoskeletal disorders (RMDs). METHODS: A multidisciplinary task force of 14 international experts was assembled with expertise from a range of disciplines including computer science and artificial intelligence. Based on a literature review of the current status of big data in RMDs and in other fields of medicine, points to consider were formulated. Levels of evidence and strengths of recommendations were allocated and mean levels of agreement of the task force members were calculated. RESULTS: Three overarching principles and 10 points to consider were formulated. The overarching principles address ethical and general principles for dealing with big data in RMDs. The points to consider cover aspects of data sources and data collection, privacy by design, data platforms, data sharing and data analyses, in particular through artificial intelligence and machine learning. Furthermore, the points to consider state that big data is a moving field in need of adequate reporting of methods and benchmarking, careful data interpretation and implementation in clinical practice. CONCLUSION: These EULAR points to consider discuss essential issues and provide a framework for the use of big data in RMDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423
High-performance medicine: the convergence of human and artificial intelligence
Topol, E. J. (2019) · Nature Medicine · doi:10.1038/s41591-018-0300-7 · Cited by 10,450 · cited 1×
“know it.[2] Big data include both clinical data (e.”
BackgroundPredicting the future - big data, machine learning, and clinical medicine
Obermeyer, Z., & Emanuel, E. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1606181 · Cited by 3,652 · cited 1×
“[17, 18, 24, 62] This is particularly needed because AI is a rapidly growing 337 field; there is an ongoing and unsolved debate, as to which methods within artificial 338 intelligence perform best.[63, 64] The comparison of AI methods was also added to 339”
MethodSun, R., Limkin, E. J., Vakalopoulou, M., Dercle, L., Champiat, S., Han, S. R., Verlingue, L., Brandao, D., Lancia, A., Ammari, S., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30413-3 · Cited by 1,236
Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0
Boers, M., Kirwan, J. R., Wells, G., Beaton, D., Gossec, L., d'Agostino, M.-A., Conaghan, P. G., Bingham, C. O., Brooks, P., Landewé, R., et al. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.11.013 · Cited by 781 · cited 1×
“43 44 While these standards regulate the way in which the data are recorded and stored, they do not control how efficient the data collection is at the care team level.”
BackgroundSelf-citationKrumholz, H. M. (2014) · Health Affairs · doi:10.1377/hlthaff.2014.0053 · Cited by 589
Koza, J. R., Bennett, F. H., Andre, D., & Keane, M. A. (1996) · Artificial Intelligence in Design ’96 · doi:10.1007/978-94-009-0279-4_9 · Cited by 361
Reproducible Research Practices and Transparency across the Biomedical Literature
Iqbal, S. A., Wallach, J. D., Khoury, M. J., Schully, S. D., & Ioannidis, J. P. A. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002333 · Cited by 310
Wallach, J. D., Boyack, K. W., & Ioannidis, J. P. A. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006930 · Cited by 269
Cited by
Digital health technologies: opportunities and challenges in rheumatology
Solomon, D. H., & Rudin, R. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0461-x · Cited by 228
Holzer, M.-T., Meinecke, A., Müller, F., Haase, I., Morf, H., Witte, T., Labinsky, H., Klemm, P., Knitza, J., & Krusche, M. (2024) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x241275818 · Cited by 12
Ethical Issues Raised by Artificial Intelligence and Big Data in Population Health: A Scoping Review
Couture, V., Roy, M.-C., Dez, E., Tremblay, F., & Bélisle-Pipon, J.-C. (2025) · Frontiers in Sociology · doi:10.3389/fsoc.2025.1536389 · Cited by 3
Metadata
- Authors
- Gossec, L., Kedra, J., Servy, H., Pandit, A., Stones, S., Berenbaum, F., Finckh, A., Baraliakos, X., Stamm, T. A., Gomez-Cabrero, D., Pristipino, C., Choquet, R., Burmester, G. R., & Radstake, T. R. D. J.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 79
- Issue
- 1
- Pages
- 69-76
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2949769604
- Cited by
- 90
- References
- 13
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases. https://app.cochat.ai/papers/10.1136/annrheumdis-2019-215694
- The paper
- Gossec, L., Kedra, J., Servy, H., Pandit, A., Stones, S., Berenbaum, F., Finckh, A., Baraliakos, X., Stamm, T. A., Gomez-Cabrero, D., Pristipino, C., Choquet, R., Burmester, G. R., & Radstake, T. R. D. J. (2020). EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2019-215694
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.